Surgery for Neuroendocrine Tumors with Xavier Keutgen, MD

Xavier Keutgen, MD, answers questions about surgery and PRRT, peptide receptor radionuclide therapy, in conjunction with surgery for neuroendocrine tumor (NET) patients in this excerpt from his Facebook Live presentation on March 18, 2019. Dr. Keutgen, a surgical oncologist and Director of the Neuroendocrine Tumor Center at the University of Chicago, spoke about surgery for people living with NETs, the importance of finding the primary site, how surgery fits into a treatment plan, and other treatment options. Watch the full Facebook Live program here:   / 407185143407054